Frequently Asked Questions What is the retatrutide dosage used in clinical trials
Bottom line: Hair loss can happen, but its usually manageable, Friedman says
As the landscape of GLP-1 medications continues to evolve, it is vital for women to stay informed about their options and seek out available resources
Dialogues Clin Neurosci 2:91100 DeMaagd G, Philip A (2015) Parkinson's disease and Its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis
When prescribing GLP-1 receptor agonists to patients with current or past substance use disorders, comprehensive assessment is essential
The first year of the pilot program ran through June 2017, and it was not renewed for a second year